Home > Insider Trading > Filing (0001213900-21-030103)

Filing Details

Accession Number:: 0001213900-21-030103
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-01 07:34:17
Reporting Period:: 2021-05-26

Accepted Time:: 2021-06-01 07:34:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1158780	Pluristem Therapeutics Inc	PSTI	Biological Products, (No Disgnostic Substances) (2836)	980351734

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1810117	Partnership Limited - Capital Wolf Clover	24 Bodenhimer Street Tel Aviv, L3 6200838		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-05-26	122,663	$3.68	3,354,825	No	4	S	Direct
Common Stock	Disposition	2021-05-26	22,015	$3.69	3,332,810	No	4	S	Direct
Common Stock	Disposition	2021-05-27	71,775	$3.69	3,261,035	No	4	S	Direct
Common Stock	Disposition	2021-05-27	24,110	$3.69	3,236,925	No	4	S	Direct
Common Stock	Disposition	2021-05-28	70,007	$3.72	3,166,918	No	4	S	Direct
Common Stock	Disposition	2021-05-28	45,000	$3.72	3,121,918	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.64 to $3.70 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.63 to $3.73 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.66 to $3.72 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.68 to $3.69 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.72 to $3.75 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.70 to $3.74 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.